Basel-based Nouscom, a clinical-stage, cancer interception focused BioTech developing next-generation immunotherapies, today announced the closing of an oversubscribed €120 million ($135 million) Series D financing to fund the advancement of…
cancer
-
-
As a first-season HGTV star, Charlie Kawas may be new to TV, but after nearly 30 years of construction work, he’s got the experience and attitude to handle just about…
-
Researchers at Mayo Clinic have designed an artificial intelligence model that can potentially predict an individual’s risk of developing pancreatic cancer years before diagnosis. Research will be presented at the…
-
Startup
London-based Big Picture Bio emerges from stealth with €2.55 million to develop AI-designed cancer drug combinations
Big Picture Bio, a London-based BioTech startup developing AI-designed combination therapies for cancer and other complex diseases, has emerged from stealth with a combined funding round of €2.55 million (£2.2…
-
Md Babul Hosen/iStock via Getty Images The Food and Drug Administration approved Telix Pharmaceuticals’ (TLX) Pixclara, a radioactive imaging drug used to help evaluate patients with glioma, the company said…
-
Arizona has sued L’Oréal, accusing the cosmetics company of concealing evidence that its chemical hair relaxer products could increase the risk of cancer in women. Arizona Attorney General Kris Mayes…
-
Stocks
‘This has been an emotionally difficult time’: My brother has cancer and my father is 94. How do I shoulder this responsibility?
“My father placed his $600,000 Wisconsin home into a revocable trust, naming my brother as beneficiary.”
-
Stocks
‘It’s heartbreaking’: My brother claimed Social Security at 70. He died from cancer after one payment. Why wait to claim?
“I’ve always been a little skeptical of the government’s encouragement to delay claiming benefits.”
-
Investment
Stock Gains on News of 70% Surge in U.S. ProSense Install Base Fuels IceCure’s (NASDAQ: ICCM) Breast Cancer Treatment Momentum
IceCure’s FDA-cleared cryoablation system for breast cancer is gaining physician and patient traction, sending shares up more than 200% on heavy volume. Investorideas.com (www.investorideas.com) a go-to platform for big investing…
-
Stocks
GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down
U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer…
